Search research articles
Contact Us
Filters
Showing results (261-270 of 420) with videos related to
Page
of 42
Sort By:
Diagnostic Microbiology and Infectious Disease
|
May 1, 1985
Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits
P C Fuchs, A L Barry, R N Jones, et al.
Applied Microbiology
|
August 1, 1972
Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus
W L Drew, A L Barry, R O'Toole, et al.
Journal of Clinical Microbiology
|
October 1, 1985
Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests
A L Barry, T L Gavan, C Thornsberry, et al.
Journal of Clinical Microbiology
|
September 1, 1986
Tentative disk diffusion susceptibility interpretive criteria for pefloxacin
P C Fuchs, A L Barry, R N Jones, et al.
Journal of Clinical Microbiology
|
July 1, 1982
Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks
A L Barry, R N Jones, C Thornsberry, et al.
The Western Journal of Medicine
|
February 1, 1976
Staphylococcal myositis in a compromised host. Successful treatment with the synergistic combination of nafcillin and gentamicin
G W Jordan, R Bauer, G A Wong, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 1980
Tentative interpretive standards for disk susceptibility tests with moxalactam (LY127935)
A L Barry, C Thornsberry, R N Jones, et al.
Journal of Clinical Microbiology
|
March 1, 1986
Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin
P C Fuchs, R N Jones, A L Barry, et al.
Journal of Clinical Microbiology
|
December 1, 1985
Cefotiam susceptibility testing criteria
P C Fuchs, A L Barry, R N Jones, et al.
Reviews of Infectious Diseases
|
November 1, 1985
Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests
A L Barry, C Thornsberry, R N Jones, et al.
Page
of 42
Search research articles
Search
Showing results (261-270 of 420) with videos related to
Sort By:
Page
of 42
Diagnostic Microbiology and Infectious Disease
|
May 1, 1985
Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits
P C Fuchs, A L Barry, R N Jones, et al.
Applied Microbiology
|
August 1, 1972
Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus
W L Drew, A L Barry, R O'Toole, et al.
Journal of Clinical Microbiology
|
October 1, 1985
Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests
A L Barry, T L Gavan, C Thornsberry, et al.
Journal of Clinical Microbiology
|
September 1, 1986
Tentative disk diffusion susceptibility interpretive criteria for pefloxacin
P C Fuchs, A L Barry, R N Jones, et al.
Journal of Clinical Microbiology
|
July 1, 1982
Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks
A L Barry, R N Jones, C Thornsberry, et al.
The Western Journal of Medicine
|
February 1, 1976
Staphylococcal myositis in a compromised host. Successful treatment with the synergistic combination of nafcillin and gentamicin
G W Jordan, R Bauer, G A Wong, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 1980
Tentative interpretive standards for disk susceptibility tests with moxalactam (LY127935)
A L Barry, C Thornsberry, R N Jones, et al.
Journal of Clinical Microbiology
|
March 1, 1986
Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin
P C Fuchs, R N Jones, A L Barry, et al.
Journal of Clinical Microbiology
|
December 1, 1985
Cefotiam susceptibility testing criteria
P C Fuchs, A L Barry, R N Jones, et al.
Reviews of Infectious Diseases
|
November 1, 1985
Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests
A L Barry, C Thornsberry, R N Jones, et al.
Page
of 42